Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Cytoplasmic and Nuclear | 6 | 2019 | 619 | 1.060 |
Why?
|
| Kupffer Cells | 2 | 2020 | 41 | 0.870 |
Why?
|
| Receptors, Calcitriol | 2 | 2020 | 140 | 0.830 |
Why?
|
| Hepatitis | 2 | 2020 | 92 | 0.700 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2009 | 217 | 0.600 |
Why?
|
| Insulin Resistance | 2 | 2020 | 728 | 0.500 |
Why?
|
| Liver | 7 | 2020 | 3086 | 0.480 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 442 | 0.470 |
Why?
|
| beta Catenin | 1 | 2015 | 689 | 0.370 |
Why?
|
| RNA Helicases | 2 | 2022 | 104 | 0.370 |
Why?
|
| Carcinogenesis | 1 | 2015 | 1035 | 0.310 |
Why?
|
| Receptors, Steroid | 1 | 2009 | 338 | 0.300 |
Why?
|
| Fatty Liver | 1 | 2009 | 247 | 0.290 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2022 | 465 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 2075 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 185 | 0.270 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 237 | 0.250 |
Why?
|
| Diet, High-Protein | 1 | 2024 | 5 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 7100 | 0.220 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 40 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 669 | 0.220 |
Why?
|
| Hepatocytes | 4 | 2020 | 337 | 0.220 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 67 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 852 | 0.190 |
Why?
|
| Mice | 14 | 2024 | 35624 | 0.180 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2019 | 12 | 0.170 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 44 | 0.170 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 44 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2020 | 151 | 0.170 |
Why?
|
| Receptors, Androgen | 2 | 2022 | 857 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 1711 | 0.160 |
Why?
|
| Animals | 15 | 2024 | 62190 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 192 | 0.150 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 7 | 0.150 |
Why?
|
| Vitamin D | 1 | 2020 | 262 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 804 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 876 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 269 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 884 | 0.140 |
Why?
|
| Retroviridae | 1 | 2017 | 373 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 726 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 7383 | 0.130 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 259 | 0.130 |
Why?
|
| Aldehydes | 1 | 2015 | 46 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 116 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 86 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 5854 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 706 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2020 | 5719 | 0.110 |
Why?
|
| Inflammation | 2 | 2020 | 2524 | 0.110 |
Why?
|
| Mitochondria | 1 | 2019 | 1303 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2015 | 391 | 0.100 |
Why?
|
| o-Aminoazotoluene | 1 | 2011 | 1 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1380 | 0.100 |
Why?
|
| Quinazolines | 1 | 2015 | 956 | 0.090 |
Why?
|
| Mice, Obese | 1 | 2009 | 92 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2022 | 9041 | 0.090 |
Why?
|
| Sulfotransferases | 1 | 2009 | 42 | 0.090 |
Why?
|
| Inactivation, Metabolic | 1 | 2009 | 42 | 0.080 |
Why?
|
| Lipogenesis | 1 | 2009 | 72 | 0.080 |
Why?
|
| Self Care | 1 | 2011 | 248 | 0.080 |
Why?
|
| Diabetic Nephropathies | 1 | 2011 | 177 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 213 | 0.080 |
Why?
|
| Obesity | 1 | 2020 | 2908 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2022 | 1830 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 404 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 743 | 0.070 |
Why?
|
| Male | 8 | 2022 | 128438 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 4141 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 146 | 0.070 |
Why?
|
| Liver Regeneration | 1 | 2006 | 133 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 14808 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 1270 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2015 | 2927 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 1487 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 1233 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5150 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3669 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2162 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 164 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 5020 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2023 | 12105 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2024 | 705 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 270903 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 43 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 421 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4961 | 0.040 |
Why?
|
| Androgens | 1 | 2022 | 513 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 112 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 295 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4804 | 0.040 |
Why?
|
| Metabolome | 1 | 2020 | 355 | 0.040 |
Why?
|
| Neoplasms | 1 | 2023 | 15893 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 16213 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 1460 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1013 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 10 | 0.030 |
Why?
|
| Imines | 1 | 2015 | 14 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 27 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2020 | 1053 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 1566 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 15904 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 700 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 529 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 842 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 909 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 1224 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 3907 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 652 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14628 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2006 | 5442 | 0.020 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2011 | 12 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 505 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 38 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 1002 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 83 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 3029 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 6417 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 610 | 0.020 |
Why?
|
| Female | 4 | 2022 | 148813 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 678 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5309 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2015 | 2379 | 0.020 |
Why?
|
| Cholestyramine Resin | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cholic Acid | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2006 | 37 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2006 | 115 | 0.020 |
Why?
|
| Growth Substances | 1 | 2006 | 327 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 521 | 0.020 |
Why?
|
| Genes, myc | 1 | 2006 | 372 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 2640 | 0.010 |
Why?
|
| DNA Replication | 1 | 2006 | 773 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 764 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 926 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2006 | 1012 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7250 | 0.010 |
Why?
|
| Diet | 1 | 2006 | 1483 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 2817 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 12022 | 0.010 |
Why?
|